Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 

Psychiatrist Researching Benefits of Ecstasy
August 2, 2004

Email
Email
Print
Print
SubscribeSubscribe
Research Summary

Michael Mithoefer, a psychiatrist in Charleston, S.C., is conducting the first U.S. trial on ecstasy's therapeutic value, the Baltimore Sun reported July 29.

Mithoefer is examining whether ecstasy can help trauma victims face their emotional wounds. "Ecstasy makes people comfortable with themselves. It brings them into the moment," said Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies, a non-profit group funding Mithoefer's research.

Mithoefer is among the few people allowed by the government to conduct human research on the benefits of ecstasy. Permission from the Drug Enforcement Administration (DEA) ca,e after nearly a decade of lobbying by researchers and doctors at Harvard University and the University of California, Los Angeles to allow the research.

"I'd like to see [ecstasy] widely used in psychiatry," said Harvard psychiatrist John Halpern, a leading proponent. "It is potentially a very valuable tool."

However, other scientists and officials are concerned over conclusions from previous studies that ecstasy causes permanent brain damage, particularly to memory.

"Let's not kid ourselves. The bulk of the evidence is on the side of risk," said David Murray, a policy analyst at the White House Office of National Drug Control Policy. "The only question is how permanent and how extensive the damage is."

Mithoefer's study will involve 20 subjects. Twelve of the subjects will be given ecstasy, while eight will receive a placebo. Over the 12-week trial, subjects will also talk with Mithoefer and another therapist to try to confront their traumas.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, focused, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post personal requests for help or general promotions for your organization (Get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.